Literature DB >> 17691108

PPARalpha and PP2A are involved in the proapoptotic effect of conjugated linoleic acid on human hepatoma cell line SK-HEP-1.

Giuliana Muzio1, Marina Maggiora, Manuela Oraldi, Antonella Trombetta, Rosa Angela Canuto.   

Abstract

Conjugated linoleic acid (CLA), found in dairy products, in beef and lamb has been demonstrated to possess anticancer properties protecting several tissues from developing cancer. Moreover, it has been shown to modulate apoptosis in several cancer cell lines. The aim of this study was to investigate which signaling transduction pathways were modulated in CLA-induced apoptosis in human hepatoma SK-HEP-1 cells. The cells exposed to CLA were evaluated for PPARalpha, PP2A, pro-apoptotic proteins Bak, Bad and caspases, and anti-apoptotic proteins Bcl-2 and Bcl-X(L). Cells were also treated with okadaic acid, a PP2A inhibitor, or with Wy-14643, a specific PPARalpha agonist. The CLA-induced apoptosis was concomitant to the increase of percentage of cells in the S phase, PPARalpha, PP2A and pro-apoptotic proteins; simultaneously, antiapoptotic proteins decreased. Inhibition of PP2A prevented apoptosis, and PPARalpha agonist showed similar effect as CLA. The increased PP2A could be responsible for the dephosphorylation of Bcl-2 and Bad, permitting apoptotic activity of Bax and Bad. The increase of caspase 8 and 9 suggested that both the intrinsic and extrinsic apoptotic pathways were induced. PP2A was probably increased by PPARalpha, since putative PPRE sequences were found in genes encoding its subunits. In conclusion, CLA induces apoptosis in human hepatoma SK-HEP-1 cells, by increasing PPARalpha, PP2A and pro-apoptotic proteins. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691108     DOI: 10.1002/ijc.23004

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.

Authors:  Barbara Gürtl; Dagmar Kratky; Christian Guelly; Lefeng Zhang; Gregor Gorkiewicz; Suman Kumar Das; Kuppusamy Palaniappan Tamilarasan; Gerald Hoefler
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

2.  Colonization by human fibroblasts of polypropylene prosthesis in a composite form for hernia repair.

Authors:  R A Canuto; S Saracino; M Oraldi; V Festa; F Festa; G Muzio; A Chiaravalloti
Journal:  Hernia       Date:  2012-09-21       Impact factor: 4.739

3.  PP2A contributes to endothelial death in high glucose: inhibition by benfotiamine.

Authors:  Y Du; A Kowluru; T S Kern
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-29       Impact factor: 3.619

4.  Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.

Authors:  Shao-Juan Gong; Xiao-Jun Feng; Wei-Hua Song; Jian-Ming Chen; Shou-Mei Wang; Dong-Juan Xing; Ming-Hua Zhu; Shu-Hui Zhang; Ai-Min Xu
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

Review 5.  Brain metabolite clearance: impact on Alzheimer's disease.

Authors:  Juan M Zolezzi; Nibaldo C Inestrosa
Journal:  Metab Brain Dis       Date:  2014-03-25       Impact factor: 3.584

6.  AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells.

Authors:  Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; Giuseppina Barrera
Journal:  PPAR Res       Date:  2012-02-29       Impact factor: 4.964

7.  PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials.

Authors:  Joseph Vamecq; Jean-Marie Colet; Jean Jacques Vanden Eynde; Gilbert Briand; Nicole Porchet; Stéphane Rocchi
Journal:  PPAR Res       Date:  2012-05-08       Impact factor: 4.964

8.  PPARalpha Ligands as Antitumorigenic and Antiangiogenic Agents.

Authors:  Ambra Pozzi; Jorge H Capdevila
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

9.  The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Cristina Toaldo; Stefania Pizzimenti; Angelo Cerbone; Piergiorgio Pettazzoni; Mario Umberto Dianzani; Carlo Ferretti
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

10.  Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma.

Authors:  Xinyan Liu; Xiaoqin Yang; Xinmei Chen; Yantao Zhang; Xuebin Pan; Guiping Wang; Yun Ye
Journal:  J Cancer       Date:  2015-09-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.